Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 19/20 | 0.58 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24792073 | 0.92 | GLP1R (0.60) | GLP1R | |
| SCHEMBL29825972 | 0.90 | GLP1R (0.51) | GLP1R | |
| SCHEMBL30740849 | 0.90 | GLP1R (0.51) | GLP1R | |
| SCHEMBL25796832 | 0.85 | GLP1R (0.56) | GLP1R | |
| SCHEMBL29157120 | 0.80 | GLP1R (0.58) | GLP1R | |
| SCHEMBL30745398 | 0.80 | GLP1R (0.58) | GLP1R | |
| SCHEMBL26481961 | 0.80 | GLP1R (0.49) | GLP1R | |
| SCHEMBL24791618 | 0.78 | GLP1R (0.59) | GLP1R | |
| SCHEMBL26908122 | 0.77 | GLP1R (0.52) | GLP1R | |
| SCHEMBL25088387 | 0.77 | GLP1R (0.61) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284795-A1 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Carmot Therapeutics, Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-117043154-A | GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof | 卡莫特医疗有限公司 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022165076-A1 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. (US) | 2022-08-04 | — | — | WO | disclosed |